Fny Investment Advisers, LLC Clovis Oncology, Inc. Call Options Transaction History

Fny Investment Advisers, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 Apr 09, 2020	SELL	$3.77 - $11.0 $30 - $88	-8 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$3.0 - $16.43 $9 - $49	3 Added 60.0%	8 $0
Q2 2019 Jul 24, 2019	BUY	$12.81 - $25.67 $64 - $128	5 New	5 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.